Results 201 to 210 of about 281,748 (215)
Some of the next articles are maybe not open access.
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.
New England Journal of MedicineBACKGROUND Polycythemia vera is a chronic myeloproliferative neoplasm characterized by erythrocytosis. Rusfertide, an injectable peptide mimetic of the master iron regulatory hormone hepcidin, restricts the availability of iron for erythropoiesis.
M. Kremyanskaya +18 more
semanticscholar +1 more source
Advances in Understanding and Management of Myeloproliferative Neoplasms
Ca-A Cancer Journal for Clinicians, 2009Paola Guglielmelli
exaly
Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
New England Journal of Medicine, 2013Roberto Marchioli +2 more
exaly
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia
Nature Medicine, 2013Carla Casu, Sara Gardenghi, Laura Breda
exaly
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
Nature, 2005Chloe James, Valérie Ugo, Judith Staerk
exaly
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics
Nature Reviews Clinical Oncology, 2009Ayalew Tefferi
exaly
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Nature Genetics, 2002Kiichi Hirota +2 more
exaly

